Total THA in adult osteonecrosis related to sickle cell disease

Clinical Orthopaedics and Related Research

Volumn 466, Issue 2, 2008, Pages 300-308

  Hernigou, Philippe ^a   Zilber, Sebastien ^a   Filippini, Paolo ^a   Mathieu, Gilles ^a   Poignard, Alexandre ^a   Galacteros, Frederic ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETABULUM; ACUTE CHEST SYNDROME; ADULT; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BONE NECROSIS; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; FEMALE; FEMORAL PERFORATION; FEMUR; FEVER; FOLLOW UP; HEMATOMA; HETEROTOPIC OSSIFICATION; HIP; HIP DISLOCATION; HUMAN; INTRAVASCULAR HEMOLYSIS; ISOLATED ACETABULAR WEAR; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PERFORATION; PERONEUS NERVE PARALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; RETROSPECTIVE STUDY; RISK FACTOR; SICKLE CELL ANEMIA; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; ADOLESCENT; ARTICLE; HIP ARTHROPLASTY; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; PROSTHESIS FAILURE; STATISTICS;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; OSTEONECROSIS; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 41949108678     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-007-0069-3     Document Type: Conference Paper

References (47)

1. Acurio MT, Friedman RJ. Hip arthroplasty in patients with sickle-cell haemoglobinopathy. J Bone Joint Surg Br. 1992;74:367-371.
2. Al-Mousawi F, Malki A, Al-Aradi A, Al-Bagali M, Al-Sadadi A, Booz MM. Total hip replacement in sickle cell disease. Int Orthop. 2002;26:157-161.
3. Babis GC, Soucacos PN. Effectiveness of total hip arthroplasty in the management of hip osteonecrosis. Orthop Clin North Am. 2004;35:359-364.
4. Bishop AR, Roberson JR, Eckman JR, Fleming LL. Total hip arthroplasty in patients who have sickle-cell hemoglobinopathy. J Bone Joint Surg Am. 1988;70:853-855.
5. Brooker AF, Bowerman JW, Robinson RA, Riley Jr LH. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55:1629-1632.
6. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-1322.
7. Clarke HJ, Jinnah RH, Brooker AF, Michaelson JD. Total replacement of the hip for avascular necrosis in sickle cell disease. J Bone Joint Surg Br. 1989;71:465-470.
8. Epps CH Jr, Bryant DD 3rd, Coles MJ, Castro O. Osteomyelitis in patients who have sickle-cell disease. Diagnosis and management. J Bone Joint Surg Am. 1991;73:1281-1294.
9. Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hips replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br. 1997;79:590-595.
10. Firth PG, Head CA. Sickle cell disease and anesthesia. Anesthesiology. 2004;101:766-785.
11. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000;82:929-938.
12. Garden MS, Grant RE, Jebraili S. Perioperative complications in patients with sickle cell disease. An orthopedic perspective. Am J Orthop. 1996;25:353-356.
13. Gruen TA, McNeice GM, Amstutz HC. 'Modes of failure' of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop Relat Res. 1979;141:17-27.
14. Gunderson C, D'Ambrosia RD, Shoji H. Total hip replacement in patients with sickle cell disease. J Bone Joint Surg Am. 1977;59:760-762.
15. Hammer M, Geier KA, Aksoy S, Reynolds HM. Perioperative care for patients with sickle cell who are undergoing total hip replacement as treatment for osteonecrosis. Orthop Nurs. 2003;22:384-397.
16. Hanker GJ, Amstutz HC. Osteonecrosis of the hip in sickle cell disease. J Bone Joint Surg Am. 1988;70:499-506.
17. Hartley WT, McAuley JP, Culpepper WJ, Engh CA Jr, Engh Sr CA. Osteonecrosis of the femoral head treated with cementless total hip arthroplasty. J Bone Joint Surg Am. 2000;82:1408-1413.
18. Hernigou P, Bachir D, Galacteros F. Avascular necrosis of the femoral head in sickle cell disease. Treatment of collapse by injection of acrylic cement. J Bone Joint Surg Br. 1993;75:875-880.
19. Hernigou P, Bachir D, Galacteros F. The natural history of symptomatic osteonecrosis in adults with sickle cell disease. J Bone Joint Surg Am. 2003;85:500-504.
20. Hernigou P, Beaujean F. Autologous bone marrow grafting of avascular osteonecrosis before collapse. J Bone Joint Surg Br. 1997;79(Supplement II):148.
21. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14-23.
22. Hernigou P, Bernaudin F, Reinert P, Kuentz M, Vernant JP. Bone marrow transplantation in sickle cell disease; effect on osteonecrosis. J Bone Joint Surg Am. 1997;79:1726-1730.
23. Hernigou P, Galacteros F, Bachir D, Goutallier D. Deformities of the hip in adults who have sickle-cell disease and had avascular necrosis in childhood. J Bone Joint Surg Am. 1991;73:81-92.
24. Hernigou P, Habibi A, Bachir D, Galacteros F. The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease J Bone Joint Surg Am. 2006;88:2565-2572.
25. Hickman JM, Lachiewicz PF. Results and complications of total hip arthroplasties in patients with sickle-cell hemoglobinopathies. Role of cementless components. J Arthroplasty. 1997;12:420-425.
26. Hodgkinson JP, Shelley P, Wroblewski BM. The correlation between the roentgenographic appearance and operative findings at the bone-cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop Relat Res. 1988;228:105-109.
27. Ilyas I, Moreau P. Simultaneous bilateral total hip arthroplasty in sickle cell disease. J Arthroplasty. 2002;17:441-445.
28. Langlais F, Kerboull M, Sedel L, Ling RSM. The 'French paradox.' J Bone Joint Surg Br. 2003;85:17-20.
29. Lifeso R. Total joint replacement in sickle cell disease. Orthop Trans. 1985;9:453.
30. Loudon JR, Charnley J. Subsidence of the femoral prosthesis in total hip replacement in relation to the design of the stem. J Bone Joint Surg Br. 1980;62:450-453.
31. Loudon JR, Older MWJ. Subsidence of the femoral component related to long-term outcome of hip replacement. J Bone Joint Surg Br. 1989;71:624-628.
32. Merle d'Aubigne R, Postel M. Functional results of hip arthroplasty with acrylic prosthesis. J Bone Joint Surg Am. 1954;36:451-475.
33. Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459-474.
34. Moran MC, Huo MH, Garvin KL, Pellicci PM, Salvati EA. Total hip arthroplasty in sickle cell hemoglobinopathy. Clin Orthop Relat Res. 1993;294:140-148.
35. Mukisi-Mukaza M, Elbaz A, Samuel-Leborgne Y, Kéclard L, Le Turdu-Chicot C, Christophe-Duchange E, Mérault G. Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease. Orthopedics. 2000;23:357-363.
36. Neumayr L, Aguilar C, Earles P, Jergesen H, Haberkern C, Kammen B, Nancarrow P, Padua E, Milet M, Stulberg B, Williams R, Orringer E, Graber N, Robertson S, Vichinsky E. The National Osteonecrosis Trial in Sickle Cell Anemia Study Group. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease: results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am. 2006;88:2573-2582.
37. Pellegrini VD Jr, Clement D, Lush-Ehmann C, Keller GS, Evarts CM. The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 1996;333:27-40.
38. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
39. Sathappan S, Ginat D, Di Cesare P. Multidisciplinary management of orthopaedic patients with sickle cell disease. Orthopedics. 2006;29:1094-1101.
40. Setty BN, Kulkami S, Rao AK, Stuart MJ. Fetal hemoglobin in sickle cell disease: relationship to erythrocyte phosphatidylserine exposure and coagulation activation. Blood. 2000;96:1119-1124.
41. Steinberg ME, Hayen GD, Steinberg D. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77:34-41.
42. Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340:1021-1030.
43. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343-1360.
44. Styles LA, Vichinsky EP. Core decompression in avascular necrosis of the hip in sickle cell disease. Am J Hematol. 1996;52:103-107.
45. Vichinsky EP, Haberkern CM, Neumayr L, Earles AN, Black D, Koshy M, Pegelow C, Abboud M, Ohene-Frempong K, Iyer RV. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group. N Engl J Med. 1995;333:206-213.
46. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, Nickerson B, Orringer E, McKie V, Bellevue R, Daeschner C, Manci EA. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000;342:1855-1865.
47. Vichinsky EP, Neumayr LD, Haberkern C, Earles AN, Eckman J, Koshy M, Black DM. The perioperative complication rate of orthopedic surgery in sickle cell disease: report of the National Sickle Cell Surgery Study Group. Am J Hematol. 1999;62:129-138.